Guardant Health earnings: what to look for from GH

What happened

Guardant Health is scheduled to report earnings this Thursday after the market closes. Last quarter, it reported revenue of $335 million, up 44.3% year on year, and its full-year revenue guidance exceeded analysts’ expectations. Analysts expect this quarter’s revenue to grow 32.2% year on year.

Confirmed

Global impact / market context

Revenue growth is a key sign of demand for Guardant Health’s testing services. If the reported growth differs from the 32.2% analysts expect, investors may reassess the company’s ability to sustain expansion, potentially changing expectations for future revenue and the value investors place on its shares.

Analyst inference

Analysts generally reaffirmed their estimates over the past 30 days, while expected growth is slower than the 38.5% recorded in the same quarter last year. Peer results offer mixed clues: NeoGenomics beat estimates, while Labcorp also exceeded expectations.

Analyst inference

What to watch

1. Check whether reported revenue growth meets the 32.2% year-on-year expectation; a shortfall or beat could shift investor views of Guardant Health’s growth outlook. Analyst inference
2. Compare reported results with the estimates analysts reaffirmed over the past 30 days, which indicate expectations for the business to stay on its current course. Confirmed
3. Watch for any update to full-year revenue guidance, since last quarter’s guidance exceeded analyst expectations and a change could reshape future sales expectations. Analyst inference

Evidence

• stockstory.org